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The selenocysteine-containing formate dehydrogen-
ase H (FDH) is an 80-kDa component of the Escherichia
coli formate-hydrogen lyase complex. The molybdenum-
coordinated selenocysteine is essential for catalytic ac-
tivity of the native enzyme. FDH in dilute solutions (30
mg/ml) was rapidly inactivated at basic pH or in the
presence of formate under anaerobic conditions, but at
higher enzyme concentrations ( 3 mg/ml) the enzyme
was relatively stable. The formate-reduced enzyme was
extremely sensitive to air inactivation under all condi-
tions examined. Active formate-reduced FDH was crys-
tallized under anaerobic conditions in the presence of
ammonium sulfate and PEG 400. The crystals diffract to
2.6 Å resolution and belong to a space group of P41212 or
P43212 with unit cell dimensions a 5 b 5 146.1 Å and c 5
82.7 Å. There is one monomer of FDH per crystallo-
graphic asymmetric unit. Similar diffraction quality
crystals of oxidized FDH could be obtained by oxidation
of crystals of formate-reduced enzymewith benzyl violo-
gen. By EPR spectroscopy, a signal of a single reduced
FeS cluster was found in a crystal of reduced FDH, but
not in a crystal of oxidized enzyme, whereas Mo(V) sig-
nal was not detected in either form of crystalline FDH.
This suggests that Mo(IV)- and the reduced FeS cluster-
containing form of the enzyme was crystallized and this
could be converted into Mo(VI)- and oxidized FeS clus-
ter form upon oxidation. A procedure that combines
anaerobic and cryocrystallography has been developed
that is generally applicable to crystallographic studies
of oxygen-sensitive enzymes. These data provide the
first example of crystallization of a substrate-reduced
form of a Se- and Mo-containing enzyme.
Molybdenum-containing enzymes are widely distributed in
both eukaryotes and prokaryotes and have important func-
tional roles in living organisms and in biogeochemical cycles (1,
2). All known Mo-containing enzymes except nitrogenase (3)
are members of a large family of proteins in which molybdenum
is coordinated to a molybdopterin (4, 5). In Escherichia coli
formate dehydrogenase, one of two known selenium-dependent
molybdoenzymes (6, 7), molybdenum is also coordinated to
selenium of a selenocysteine residue (7, 8).
Although several molybdopterin-dependent enzymes have
been studied extensively by mechanistic and structural meth-
ods for decades (9, 10), there is still a lack of definitive infor-
mation on reaction mechanisms and three-dimensional struc-
tures. X-ray structural analyses of some of these proteins have
been hampered by microheterogeneity due to the partial loss of
cofactors or their components, as well as by enzyme instability
which usually resulted in failure in crystallization or in de-
creased diffraction of the crystals. The crystallization of two
molybdopterin-containing enzymes, a native aldehyde oxi-
doreductase from Desulfovibrio gigas (11, 12) and a bovine
xanthine oxidase, has been reported (13).
Important information on molybdenum-containing enzymes
perhaps can be inferred from studies on tungsten-containing
enzymes. The structure of the tungstoenzyme, aldehyde ferre-
doxin oxidoreductase, from Pyrococcus furiosus was solved re-
cently at 2.3-Å resolution (14). The active center tungsten is not
bound to amino acid residues of the polypeptide chain as sug-
gested for certain bacterial molybdoenzymes (7); rather, tung-
sten is coordinated to two identical molecules of molybdopterin,
each molybdopterin providing two thiolene sulfurs for tungsten
coordination. By analogy, these studies supported the proposed
structure of the molybdopterin molecule and the proposed type
of metal-molybdopterin coordination. However, the archaebac-
terial aldehyde ferredoxin oxidoreductase does not have amino
acid sequence homology to known molybdenum-containing
enzymes.
Substrates of molybdoenzymes react with molybdenum ac-
tive centers resulting in the redox transformations of these
centers and the formation of unstable enzymic intermediates.
Some of these are paramagnetic species which have been the
subject of extensive studies by EPR, ENDOR (electron nuclear
double resonance), and EXAFS (extended x-ray absorption fine
structure) spectroscopies (2, 9). However, the interpretation of
the data obtained with these techniques depends largely upon
our knowledge of three-dimensional structures, especially the
structures of reduced forms of the enzymes.
Selenium- and molybdenum-containing formate dehydrogen-
ase H (FDH)1 and hydrogenase 3 are components of the for-
mate-hydrogen lyase complex, which in vivo decomposes formic
acid to carbon dioxide and hydrogen under anaerobic condi-
tions (15). FDH was purified recently (16–18) and was shown
to contain a number of redox centers: a molybdopterin cofactor
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consisting of molybdenum coordinated to molybdopterin gua-
nine dinucleotide (16), a selenocysteine (SeCys) residue (8)
encoded by UGA (19), and a FeS cluster (16). The catalytic
activity of mutant enzyme in which SeCys-140 was substituted
with Cys was only 0.3% that of the wild type enzyme (18), and
a Ser-140 mutant was inactive (20). EPR studies of formate-
reduced Mo(V)-containing FDH have demonstrated the direct
coordination of selenium to molybdenum (7). FDH is extremely
oxygen-sensitive, and isolation of the active enzyme can be
achieved only under strictly anaerobic conditions. In the pres-
ence of substrate, formate, the enzyme is inactivated in a
time-dependent manner (16).
In spite of its oxygen sensitivity, FDH may be a useful model
for studies on molybdenum- and selenium-containing met-
alloenzymes. Since the enzyme is a monomer of 80 kDa and
lacks flavin, it has certain advantages over more complex mul-
ticomponent systems. Due to the presence of selenium in the
molybdenum coordination sphere, additional methods could
be applied to investigate enzyme structure and reaction
mechanism.
Herein we present an improved purification procedure,
methods of stabilization, and crystallization of substrate-re-
duced enzyme, together with a procedure for oxidation of the
enzyme in crystals and preliminary crystallographic analysis of
formate dehydrogenase.
EXPERIMENTAL PROCEDURES
Purification—Formate dehydrogenase H was isolated from E. coli
strain FM911 containing plasmid pFM20 (16). Cells were grown anaer-
obically in the presence of 1 mM sodium selenite as described previously
(16, 20). All purification steps were performed in a nitrogen atmosphere
containing 1–5% hydrogen in the NIH Anaerobic Laboratory operating
at ,1 ppm of oxygen (21). All solutions were prepared anaerobically and
sparged additionally for 15 min with oxygen-free argon prior to use. All
plastic vessels and equipment were kept for 3–4 days under strictly
anaerobic conditions prior to use.
The procedure for isolation of FDH from 300 g of cells was essentially
the same as described previously (16), except that cells were ruptured
by sonication and the isolation procedure was scaled up 15 times to
obtain larger amounts of protein. The entire purification procedure was
completed in 3–4 days. FDH obtained after the phenyl-Sepharose and
hydroxyapatite chromatographic steps was more than 95% pure accord-
ing to analytical gel filtration and SDS-PAGE analyses. 50 mg of en-
zyme was obtained with a specific activity of 950 mmol/min/mg of
protein. To further purify the enzyme, an additional ion-exchange chro-
matographic step was designed, in which FDH in 25 mM MES/NaOH,
pH 6.0, 3 mM sodium azide, was applied to a DEAE-HPLC column
equilibrated with 25 mM sodium phosphate, pH 6.3, 3 mM sodium azide
(buffer A). The enzyme was eluted with a linear gradient of 0 to 200 mM
sodium sulfate in buffer A. The active enzyme fractions were pooled and
made to 25 mM MES/NaOH, pH 6.0, 5 mM sodium azide, 1 mM sodium
phosphate, 3 mM sodium sulfate by diafiltration on an Amicon ultrafil-
tration unit fitted with a YM-10 membrane. FDH was concentrated to
11 mg/ml, passed through a 0.22-mm filter and frozen by dripping into
liquid nitrogen, then stored in liquid nitrogen. No loss of activity was
detected in thawed samples. For experiments with FDH, droplets of the
frozen enzyme were brought into an anaerobic chamber or the NIH
Anaerobic Laboratory and thawed in anaerobic microcentrifuge tubes.
Studies on Stability—The stability of the DEAE-purified FDH was
studied at high and low protein concentrations in pH 6.0 and pH 7.5
buffers in the NIH Anaerobic Laboratory. Solutions containing 300 mg
or 3 mg of FDH in 100 ml of 50 mM MES/NaOH, pH 6.0, 3 mM sodium
azide or 50 mM HEPES/NaOH, pH 7.5, 3 mM sodium azide were incu-
bated in 1.5-ml microcentrifuge tubes (gas phase 99% N2, 1% H2) at
room temperature for the indicated periods of time, and, thereafter,
activity of the enzyme was measured in the standard assay. To test the
effect of formate on stability of FDH under these conditions, 10 mM
sodium formate was included in the incubation solutions. The stability
of FDH under crystallization conditions in the presence of 2 M ammo-
nium sulfate and 2% PEG 400 was also tested in the presence and in the
absence of sodium formate.
To test the effect of oxygen on stability of FDH, 50-ml samples
containing 150 mg, 15 mg, or 1.5 mg of FDH in 25 mM MES/NaOH, pH
6.0, and 3 mM sodium azide were incubated for 2 h in closed 1.5-ml
microcentrifuge tubes (gas phase air) at room temperature. The sam-
ples then were brought into the NIH Anaerobic Laboratory, flushed
with argon, transferred into deoxygenated microcentrifuge tubes, and
incubated overnight (gas phase 99% N2, 1% H2) at 4 °C. Catalytic
activities were measured in the standard assays and compared to the
activity of a control sample (150 mg of FDH/50 ml), which was not
exposed to air and had been kept in the NIH Anaerobic Laboratory.
These experiments were performed both in the presence and in the
absence of 20 mM sodium formate.
Crystallization—Due to the extreme oxygen sensitivity of the en-
zyme, crystallization experiments were carried out in an anaerobic
glove chamber (B-type, Coy Laboratory Products, Inc., Grass Lake, MI)
under a nitrogen atmosphere in the presence of 1–4% H2. Oxygen
concentration inside the chamber was controlled to less than 1 ppm. All
buffers and solutions used in crystallization experiments were sparged
with oxygen-free nitrogen gas to remove traces of dissolved oxygen prior
to use. Protein samples of FDH were transported into the chamber in
liquid nitrogen and thawed prior to use. To grow crystals, 5–10 aliquots
of 11 mg/ml FDH was mixed with an equal amount of precipitation
reagent and equilibrated in a hanging drop against the well precipita-
tion solution using a Linbro plate (22). The well solution contained
1.5–1.7 M ammonium sulfate, 1% PEG 400, 20 mM sodium formate, and
100 mM HEPES/NaOH at pH 7.5. Crystals grew at room temperature
for a period of 1 to 2 weeks.
Cryofreezing of FDH Crystals—FDH crystals were first equilibrated
with the well solution before cryofreezing. A pre-equilibrated FDH
crystal was then transferred together with about 5–10 ml of the original
well solution to a reservoir of 0.1 ml of cryoprotectant solution. The
cryoprotectant solution contained 1.4 M lithium sulfate, 1% PEG 400, 20
mM sodium formate, 100 mM HEPES/NaOH at pH 7.5, and 25% glyc-
erol. Immediately after the first transfer, the crystal was picked up on
a cryoloop that was mounted on a stainless steel cap (Charles Supper
Catalog No. 485SS), in a drop-and-pick fashion and was frozen in liquid
nitrogen.
X-ray Crystallographic Data Collection and Processing—Frozen crys-
tals were quickly transferred from storage liquid nitrogen to a cold
2180 °C nitrogen stream centered at the goniometer head in the x-ray
beam path. Data were collected using an R-AXIS imaging plate system
with a focusing mirror (Molecular Structure Corp.) mounted on a
Rigaku RU-200 rotating anode x-ray generator. Crystals were oscillated
at 2-degree intervals with a detector distance of 175 mm. The oscillation
images were processed using either R-AXIS software package (23) or
HKL version 1.0 (DENZO and SCALEPACK) (24). To prevent ice for-
mation on the frozen crystals during data collection, a complete enclo-
sure was built surrounding the crystal to provide a local near zero
humidity atmospheric environment.
EPR Spectroscopy—Preparation of EPR samples of FDH was per-
formed as described previously (7). To prepare formate-reduced enzyme
samples, 11 mg/ml FDH in 100 mM HEPES/NaOH, pH 7.5, was incu-
bated in the presence of 10 mM sodium formate at room temperature for
1 min followed by freezing of the samples in liquid nitrogen. For EPR
study of crystallized FDH, crystals were frozen in liquid nitrogen in a
manner similar to freezing of the crystals for x-ray data collection.
Frozen crystals were then transferred into EPR tubes. EPR spectra
were recorded with a Bruker X-band ESP300 spectrometer (7). Spectra
accumulation was performed at 130 K and at 35 K, 5 G modulation
amplitude, and 9.46 GHz microwave frequency.
Activity Assessment of FDH Crystals—To determine whether crystal-
lized FDH was active, crystals of 0.2–0.4 mmmaximal dimensions were
incubated for 5 min in a solution similar to the well solution except that
formate was omitted. Crystals were then dissolved in 300 ml of 25 mM
MES/NaOH, pH 6.0, 3 mM sodium azide. Formate dehydrogenase and
hydrogenase specific activities of the enzyme were measured in the
standard assays and compared to those of the enzyme that was used for
crystallization.
Oxidation of Formate-reduced Crystals—Prior to oxidation, formate-
reduced crystals were equilibrated in a formate-free solution. A 0.4-mm
crystal in a 10-ml drop was quickly washed 4 times with 50 ml of the well
solution lacking sodium formate. The crystal in a 1–2-ml solution was
transferred into 750 ml of fresh formate-free well solution and incubated
for 15 min, then transferred into another 750 ml of solution and again
incubated for 15 min. The formate-free crystals obtained in this way
were oxidized with 0.1–10 mM benzyl viologen in 750 ml of formate-free
well solution for 30–60 min. For experiments with inhibitors, benzyl
viologen-oxidized crystals were incubated in 750 ml of formate-free well
solution containing either 10 mM sodium azide, 50 mM sodium hy-
pophosphate, or 50 mM sodium nitrite for 30 min. Crystals were frozen
as described above except that the cryoprotectant solution did not
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contain sodium formate.
Other Methods—Benzyl viologen-dependent formate dehydrogenase
assays were performed as described (16). To measure hydrogenase
activity, a 1-ml mixture containing 2 mM benzyl viologen and 50 mM
Tris/HCl, pH 7.5, was bubbled with hydrogen gas for 5 min. Reaction
was initiated by the addition of 10 ml of enzyme and monitored by the
increase in absorption at 578 nm due to the reduction of benzyl viologen.
Electronic absorption spectra of FDH samples were recorded anaerobi-
cally with a Hewlett Packard model 8452A spectrophotometer. Native
and SDS-PAGE analyses were carried out aerobically on 12% gels
(Novex, San Diego). Analytical gel filtration was performed aerobically
using a TSK G3000 HPLC column equilibrated with 100 mM Tris/HCl,
pH 7.5, 100 mM NaCl.
RESULTS AND DISCUSSION
Purity of FDH—The preliminary experiments on crystalliza-
tion of FDH were performed using enzyme of more than 95%
purity isolated according to a previously published procedure
(16). In addition to FDH activity, this enzyme exhibited detect-
able hydrogenase activity. With this enzyme preparation, for-
mation of enzyme nucleations was observed in the presence of
ammonium sulfate and PEG 400, but no crystals suitable for
data collection were obtained.
An additional ion-exchange chromatographic purification
step separated some impurities from the main FDH peak (Fig.
1). The purity of the resulting FDH preparation was confirmed
with native and SDS-PAGE, analytical gel filtration and mass
spectrometry (MALDI) analyses (not shown). A molecular mass
of about 80 kDa estimated with these techniques matched the
molecular mass predicted from the FDH gene sequence (79.1
kDa), indicating the presence of a full-length polypeptide. The
UV-visible absorption spectrum (Fig. 2) was characteristic of a
protein containing iron-sulfur clusters with a 280 nm to 400 nm
absorbance ratio of 9. Residual trace amounts of hydrogenase
activity were not separated from formate dehydrogenase activ-
ity by the DEAE-chromatographic step and later by crystalli-
zation. The ratio of formate dehydrogenase specific activity to
hydrogenase specific activity was 733 for the isolated enzyme
and 933 for the enzyme obtained from dissolved crystals.
Stability of Enzyme—It was found previously that FDH is
most stable at lower pH (maximum stability at pH 6.0) and
most active at higher pH (maximum activity at pH 8.0). It was
suggested that both pH profiles might reflect the ionization of
a single functional group (16). Sodium formate, the physiolog-
ical substrate for FDH, inactivated the enzyme in a time-de-
pendent manner (16). These results have been reproduced in
our hands. The enzyme was found to have higher stability at
pH 6.0 than at pH 7.5, and at each of these pH values the
presence of formate resulted in inactivation of FDH (Fig. 3A). It
was observed, however, that stability of FDH was highly de-
pendent on the concentration of the enzyme. At 3 mg/ml, FDH
was very stable both at pH 7.5 and in the presence of 10 mM
sodium formate (Fig. 3B). Thus, an increase in enzyme concen-
tration led to stabilization of FDH in a state where it exhibited
maximal activity. This stabilization effect was presumably due
to an increase in the ratio of highly reactive reduced FDH to
FIG. 1. Purification of FDH on a DEAE-HPLC column. FDH
purified by phenyl-Sepharose and hydroxyapatite chromatography was
further purified on a DEAE-HPLC column as described under “Exper-
imental Procedures.” Elution was followed by absorption measure-
ments at 280 nm. The main peak eluted at 1570 s represents FDH.
Minor peaks represent impurities.
FIG. 2. Absorption spectra of FDH. The electronic absorption spec-
trum of “as isolated” FDH is shown (lower spectrum). The area where
FeS clusters absorb is shown in the enlarged scale (upper spectrum).
Inset shows the difference spectrum (oxidized enzyme minus formate
reduced enzyme). The maximum in the difference spectrum is at 450
nm due to the reduction of FeS clusters. The enzyme was reduced with
10 mM formate for 5 min at room temperature.
FIG. 3. Stability of FDH: effect of pH, sodium formate, and
enzyme concentration. FDH samples were incubated in the presence
of various compounds at room temperature as described under “Exper-
imental Procedures.” At the indicated times, aliquots of the solutions
were taken for activity measurements. Activities remaining are ex-
pressed as percent of initial activity. A, samples contained 3 mg of FDH
per 100 ml. Buffers were 50 mM MES/NaOH, pH 6.0, or 50 mM HEPES/
NaOH, pH 7.5. B, 3 mg of FDH/100 ml in 50 mMMES/NaOH, pH 6.0 (M),
3 mg of FDH/100 ml in 50 mM HEPES/NaOH, pH 7.5, 10 mM sodium
formate (E); 300 mg of FDH/100 ml in 50 mM HEPES/NaOH, pH 7.5, 10
mM sodium formate (F).
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traces of oxygen in the solution.
To test the stability of reduced enzyme at high pH in the
presence of oxygen, FDH samples were exposed to air for 2 h
(Fig. 4). After this treatment, no activity was detected in the
reduced FDH samples at any concentration of the enzyme
studied. Interestingly, as isolated FDH was much less sensitive
to oxygen. In one experiment, 94% of initial activity remained
in the enzyme sample after a 1-h exposure of FDH (6 mg/ml
protein) to air. Concentrated FDH (3 mg/ml) was more stable
than enzyme diluted 100-fold (0.03 mg/ml), although even di-
luted enzyme had significant activity (Fig. 4).
The previously observed greater sensitivity of an isolated
FDH toward oxygen exposure (16) could possibly be explained
by the presence of oxygen-sensitive reduced FDH species in
native FDH preparations. This is consistent with our observa-
tions that a low reduced Mo(V) EPR signal could be detected in
certain isolated FDH preparations.
Crystallization and Cryoprotection of FDH Crystals—Dif-
fraction quality FDH crystals were obtained at room tempera-
ture by the hanging drop method using ammonium sulfate and
PEG 400 as precipitants (Fig. 5). These crystals grew only
under strictly anaerobic conditions. Attempts to carry out crys-
tallizations aerobically failed to yield any crystals. The most
competent state of the enzyme for crystallization proved to be
freshly prepared protein samples from liquid nitrogen storage.
Protein remained competent for crystallization for about 2
weeks. This strong time dependence of crystallization indicates
a partial inactivation of the enzyme in 2 weeks even under
anaerobic conditions, presumably due to oxidative damage to
the enzyme by traces of oxygen. The diffraction quality of
already grown crystals was markedly reduced by oxygen and,
as a result, only freshly grown crystals were used in data
collections.
Crystals were first frozen in liquid nitrogen before removal
from the anaerobic chamber for data collection. Once frozen,
these crystals appear to be insensitive to the level of oxygen
and thus can be handled outside the anaerobic chamber. A
number of cryoprotectant solutions, including ethylene glycol,
PEG 400, sucrose, and glycerol at different concentrations,
were tested to obtain satisfactory freezing of the crystals. The
most effective reagents for cryofreezing of FDH crystals contain
25%-30% glycerol or sucrose with 1.7 M ammonium sulfate, 1%
PEG 400, and 0.1 M HEPES/NaOH at pH 7.5. Glycerol solution
gave less mosaicity of diffraction than the sucrose solution. The
requirement of a high concentration of glycerol is thought to be
necessary to suppress a high spontaneous crystal-forming
tendency of ammonium sulfate during cryofreezing, and the
elevated concentration of ammonium sulfate might be needed
to stabilize crystals in 25–30% glycerol. In order to reduce the
crystallization tendency of ammonium sulfate and reduce the
amount of glycerol used, we subsequently replaced ammonium
sulfate in the cryoprotectant with lithium sulfate and achieved
the same or better diffraction of crystals using 1.4 M lithium
sulfate and 20–25% glycerol (25). Both a step transfer proce-
dure, in which a crystal was transferred stepwise to 5, 10, 15,
20, and 25% glycerol solutions, and a quick exchange proce-
dure, in which a crystal was directly transferred into the final
cryopreserving solution, were tested for applying the cryopre-
serving solution. Only the quick exchange procedure gave sat-
isfactory cryofreezing results.
Preliminary Crystallographic Analysis of FDH Crystals—A
typical FDH crystal measured 0.3 3 0.3 3 0.3 mm and dif-
fracted to 2.6-Å resolution (Fig. 6) on a Rigaku RU200 rotating
anode x-ray generator equipped with an R-AXIS imaging plate
system. The crystals belonged to a space group P41212 or
P43212 with cell dimensions a 5 b 5 146.1 Å and c 5 82.7 Å.
The calculated Matthews’ volume (26) was 2.8 assuming one
monomer in each crystallographic asymmetric unit. A native
data set was collected to 3.0-Å resolution that consisted of
17,511 unique reflections with a merging R-factor of 6.6%
(Table I). The completeness of the data was 96%.
Properties of Crystals—An important issue of these studies
was to determine whether the FDH crystals obtained repre-
sented active, formate-reduced enzyme. A 1-month-old crystal
of FDH was dissolved in 25 mM MES/NaOH, pH 6.0, and FDH
specific activity was determined in the standard assay and
FIG. 4. Oxygen sensitivity of FDH. FDH samples of varying en-
zyme concentration in the presence or in the absence of sodium formate
were prepared and exposed to air as described under “Experimental
Procedures.” Activities of FDH samples are expressed as percent of
activity of a FDH control sample which was not exposed to air.
FIG. 5. Crystal of formate dehydrogenase H. The crystal grew in
approximately 1 week and measured 0.3 3 0.3 3 0.4 mm in size. The
direction of a 4-fold symmetry axis is shown with an arrow.
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compared to the specific activity of the enzyme before crystal-
lization. The formate dehydrogenase specific activity of the
enzyme from the dissolved crystal was 41% of the original. In
another experiment, 70% of the formate dehydrogenase specific
activity and 56% of the hydrogenase specific activity were
recovered from six 2-week-old crystals combined and redis-
solved in one solution. Assuming partial inactivation of the
enzyme during crystallization, storage, and dissolving the crys-
tals, activity of FDH present in a freshly formed crystal might
be as high as 100%. The electronic absorption spectrum of the
redissolved crystal was typical of formate-reduced FDH indi-
cating that the FeS center of the enzyme was in the reduced
state.
The redox states of cofactors in FDH crystals were studied
with EPR spectroscopy. The signal of a single reduced FeS
cluster was observed at 35 K with components corresponding to
those of the FeS cluster of FDH in solution (Fig. 7). The FeS
signal in the crystal was dependent on the orientation of the
sample in the magnetic field of the EPR spectrometer. The
complexity of the FeS cluster signal of crystallized FDH sug-
gests that FeS clusters of several orientations are present in
the crystal. None of the EPR signals presented in Fig. 7, spectra
b and c, were observed at 130 K, providing further evidence
that these signals are derived from FeS clusters. The Mo(V)
signal which is observed in solutions of FDH both at 35 and 130
K (Fig. 7, spectrum a) was not detected in crystals at these
temperatures; therefore, FDH crystals do not contain Mo(V)
species. These data suggest that the Mo(IV)- and reduced FeS
cluster-containing form of the enzyme was crystallized.
Although sodium formate was essential for FDH crystalliza-
tion, the crystal remained intact when equilibrated in a similar
solution lacking sodium formate. When a formate-free crystal
was oxidized by 0.1–10 mM benzyl viologen, the crystal devel-
oped a dark blue color due to the reduced benzyl viologen. It
was observed that reduced benzyl viologen binds tightly to
FDH crystals and could not be easily oxidized with aerobic
solutions. EPR spectroscopy was used to follow oxidation of
crystals. A signal of reduced FeS cluster was observable after
equilibration of the crystals in formate-free solutions. However,
neither a Mo(V) signal nor a reduced FeS cluster signal was
detected after a 30-min incubation of formate-free crystal in 10
mM benzyl viologen.
Ammonium bicarbonate (100 mM) was also tested as an
FIG. 6. A 1-degree oscillation image of a native FDH crystal.
The image was taken with an R-AXIS detector at a crystal to detector
distance of 175 mm and a 5-degree 2u swing angle. The exposure time
was 30 min.
TABLE I










a Rmerge 5 ShIh 2 ^Ih&/Sh Ih. Ih is the intensity of reflection h. Sh is
the sum over all reflections.
FIG. 7. EPR spectra of FDH in solution and FDH crystals. a,
EPR signal of the frozen solution of FDH. Enzyme was treated with 10
mM formate for 1 min. The spectrum is a superposition of Fe2S2 EPR
signal with g-factors of 1.840, 1.957, and 2.04, and Mo(V) EPR signal
with g-factors of 2.094 and 2.0. The first signal can be detected at
temperatures below 50 K, whereas the second signal can be observed at
130 K and below. b, EPR spectrum of a single frozen FDH crystal
obtained as described under “Experimental Procedures.” c, same as b
but the sample was turned by 45 degrees in the magnetic field of the
EPR spectrometer. Before plotting, spectrum c was multiplied by 0.25.
Spectra a, b, and c were recorded at 35 K at microwave powers of 0.81,
3.8, and 3.8 milliwatts, respectively.
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oxidant for formate-free reduced crystals. Although the reduc-
tion of FDH by formate in solutions is reversible (17), added
bicarbonate did not reproduceably cause oxidation of crystals,
presumably due to the low concentration of carbon dioxide in
equilibrium with bicarbonate at pH 7.5. Oxidation of crystals
from the Mo(IV)-reduced FeS cluster form to the Mo(VI)-oxi-
dized FeS cluster form of the enzyme or incubations of oxidized
crystals with inhibitors (azide, nitrite, and hypophosphate) did
not change the diffraction quality of crystals. Since crystals of
oxidized FDH could be obtained from formate-reduced crystals,
a potential to solve the structures of both reduced and oxidized
FDH is provided.
The studies described here for development of an improved
purification and stabilization protocol have resulted in the first
crystallization of a substrate-reduced molybdenum- and sele-
nium-containing enzyme in its active form.
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